Acceleron Pharma
Cambridge, US
Biotech
Founders & leadership
SE
STEVEN ERTELNamed on SEC filing
RS
ROBERT STEININGERNamed on SEC filing
KF
KEVIN F. MCLAUGHLINNamed on SEC filing
RP
RICHARD POPSNamed on SEC filing
EM
EDWIN M. KANIANamed on SEC filing
CL
CARL L. GORDONNamed on SEC filing
JG
JEAN GEORGENamed on SEC filing
WW
WYLIE W. VALENamed on SEC filing
TG
TERRANCE G. MCGUIRENamed on SEC filing
JK
JOHN KNOPFNamed on SEC filing
AB
ANTHONY B EVNINNamed on SEC filing
ML
MATTHEW L. SHERMANNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$30.5M disclosed across 1 round · 2011
▶$30.5MraisedJan 2012 · 47 investors · BiotechnologyRule 506(b)
▶$30.5MraisedJan 2012 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- STEVEN ERTELExecutive Officer
- ROBERT STEININGERExecutive Officer
- KEVIN F. MCLAUGHLINExecutive Officer
- RICHARD POPSDirector
- EDWIN M. KANIADirector
- CARL L. GORDONDirector
- JEAN GEORGEDirector
- WYLIE W. VALEDirector
- TERRANCE G. MCGUIREDirector
- JOHN KNOPFExecutive Officer, Director
- ANTHONY B EVNINDirector
- MATTHEW L. SHERMANExecutive Officer
- JOSEPH S. ZAKRZEWSKIDirector
- GEORGE GOLUMBESKIDirector
- TOM MANIATISDirector
- Offering amount
- $30.5M
- Amount sold
- $30.5M
- First sale
- Dec 2011
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Acceleron Pharma raised?
- Acceleron Pharma has disclosed $30.5M raised across 1 round.
- Where is Acceleron Pharma headquartered?
- Acceleron Pharma is headquartered in Cambridge, US.